Sandu Pharmaceuticals Limited (BOM:524703)
India · Delayed Price · Currency is INR 38.22
+0.10 (0.26%)
At close: Sep 4, 2026
Sandu Pharmaceuticals Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Operating Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 17.66 | 15.49 | 14.61 | 15.21 | 15.89 |
Depreciation & Amortization | 6.77 | 6.6 | 5.67 | 5 | 4.97 |
Other Amortization | - | 0.11 | 0.16 | 0.17 | 0.34 |
Loss (Gain) From Sale of Assets | - | 0.03 | - | - | - |
Provision & Write-off of Bad Debts | 1.8 | 1.61 | 0.43 | 0.38 | 0.4 |
Other Operating Activities | 2.74 | -1.1 | -1.03 | -0.8 | -0.85 |
Change in Accounts Receivable | -8.34 | -0.5 | -1.19 | -8.38 | 13.17 |
Change in Inventory | 36.77 | -18.98 | 20.75 | -30.53 | -1.34 |
Change in Accounts Payable | -0.2 | 2.93 | -42.06 | 15.8 | 1.48 |
Change in Other Net Operating Assets | 3.96 | 3.31 | 10.25 | 5.38 | -24.55 |
Operating Cash Flow | 61.16 | 9.5 | 7.6 | 2.21 | 9.49 |
Operating Cash Flow Growth | 543.47% | 25.07% | 243.69% | -76.69% | -87.50% |
Investing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Capital Expenditures | -7.2 | -9.38 | -14.25 | -10.69 | -8.41 |
Divestitures | - | 0.07 | - | - | - |
Investment in Securities | 0.92 | 6.41 | -0.41 | 14.47 | -47.13 |
Other Investing Activities | 0.59 | 1.1 | 1.59 | 1.58 | 0.82 |
Investing Cash Flow | -5.69 | -1.8 | -13.07 | 5.37 | -54.72 |
Financing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Long-Term Debt Issued | - | 4.14 | 0.63 | - | - |
Short-Term Debt Repaid | - | - | - | - | -0.19 |
Long-Term Debt Repaid | -0.58 | - | - | - | - |
Total Debt Repaid | -0.58 | - | - | - | -0.19 |
Net Debt Issued (Repaid) | -0.58 | 4.14 | 0.63 | - | -0.19 |
Issuance of Common Stock | - | - | - | 13.2 | 13.81 |
Common Dividends Paid | -7.73 | -7.73 | -7.25 | -6.61 | -3.17 |
Other Financing Activities | -1.12 | -1.03 | -0.63 | -0.8 | -1.1 |
Financing Cash Flow | -9.43 | -4.62 | -7.24 | 5.79 | 9.34 |
Net Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Miscellaneous Cash Flow Adjustments | - | -0 | 0 | - | - |
Net Cash Flow | 46.04 | 3.08 | -12.71 | 13.37 | -35.89 |
Free Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | 53.96 | 0.12 | -6.65 | -8.48 | 1.08 |
Free Cash Flow Growth | 43412.10% | - | - | - | -98.56% |
Free Cash Flow Margin | 7.71% | 0.02% | -0.99% | -1.30% | 0.16% |
Free Cash Flow Per Share | 5.58 | 0.01 | -0.69 | -0.90 | 0.13 |
Levered Free Cash Flow | 48.08 | -1.78 | -8.99 | -11.3 | -1.07 |
Unlevered Free Cash Flow | 48.75 | -1.18 | -8.65 | -10.85 | -0.61 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash Interest Paid | 1.08 | 0.95 | - | 0.24 | 0.74 |
Cash Income Tax Paid | 7.5 | 5.83 | 4.99 | 7 | 8.77 |
Change in Working Capital | 32.18 | -13.23 | -12.24 | -17.74 | -11.25 |